About Tasly
Tasly is a company based in Tianjin (China) founded in 1994 by XiJun Yan.. Tasly has raised $84.5 million across 1 funding round from investors including Ally Bridge Group and BOCOM International. The company has 10,960 employees as of December 31, 2024. Tasly operates in a competitive market with competitors including Methuselah Medical Technology, Yixintang Pharmaceutical, BiggerMax, Chiatai Qingjiang Pharmaceutical and East Earth Trade Winds, among others.
- Headquarter Tianjin, China
- Employees 10960 as on 31 Dec, 2024
- Founders XiJun Yan
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tasly Pharmaceutical Group Co. Ltd. Class A
-
Annual Revenue
$1.15 B (USD)-2.03as on Dec 31, 2024
-
Net Profit
$130.91 M (USD)-10.78as on Dec 31, 2024
-
EBITDA
$264.41 M (USD)-1.06as on Dec 31, 2024
-
Total Equity Funding
$84.5 M (USD)
in 1 rounds
-
Latest Funding Round
$84.5 M (USD), Series C
Jul 12, 2018
-
Investors
Ally Bridge Group
& 1 more
-
Employee Count
10960
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tasly
Tasly is a publicly listed company on the SSE with ticker symbol 600535 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Tasly
Tasly has successfully raised a total of $84.5M through 1 strategic funding round. The most recent funding activity was a Series C round of $84.5 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $84.5M
-
First Round
First Round
(12 Jul 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2018 | Amount | Series C - Tasly | Valuation | Ally Bridge Group , BOCOM International |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tasly
Tasly has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ally Bridge Group and BOCOM International. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tasly
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tasly
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tasly Comparisons
Competitors of Tasly
Tasly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Methuselah Medical Technology, Yixintang Pharmaceutical, BiggerMax, Chiatai Qingjiang Pharmaceutical and East Earth Trade Winds, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical nutrition products are manufactured and supplied internationally.
|
|
| domain | founded_year | HQ Location |
Chinese pharmaceutical products are distributed and retailed by Yixintang Pharmaceutical.
|
|
| domain | founded_year | HQ Location |
Distributes high-quality Chinese medicines to businesses and partners.
|
|
| domain | founded_year | HQ Location |
Acts as a distributor of medicines including garlicin, celecoxib, altretamine, and others.
|
|
| domain | founded_year | HQ Location |
Distributes complementary and alternative medicines to support health and wellness needs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tasly
Frequently Asked Questions about Tasly
When was Tasly founded?
Tasly was founded in 1994 and raised its 1st funding round 24 years after it was founded.
Where is Tasly located?
Tasly is headquartered in Tianjin, China.
Is Tasly a funded company?
Tasly is a funded company, having raised a total of $84.5M across 1 funding round to date. The company's 1st funding round was a Series C of $84.5M, raised on Jul 12, 2018.
How many employees does Tasly have?
As of Dec 31, 2024, the latest employee count at Tasly is 10,960.
What is the annual revenue of Tasly?
Annual revenue of Tasly is $1.15B as on Dec 31, 2024.
What does Tasly do?
Manufacture and distributor of traditional Chinese medicine. It is a China-based company principally engaged in the manufacture and distribution of TCM. It provides compound Danshen dripping pills that prevent and treat coronary heart disease and angina pectoris, nourishing blood and cleaning brain granules. It also offers many medicines that help to relieve headaches, as well as bupleurum pills, huoxiangzhengqi pills, pills for stomach diseases, and andrographolide pills, among others.
Who are the top competitors of Tasly?
Tasly's top competitors include Methuselah Medical Technology, Yixintang Pharmaceutical and BiggerMax.
Is Tasly publicly traded?
Yes, Tasly is publicly traded on SSE under the ticker symbol 600535.
Who are Tasly's investors?
Tasly has 2 investors. Key investors include Ally Bridge Group, and BOCOM International.
What is Tasly's ticker symbol?
The ticker symbol of Tasly is 600535 on SSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.